These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1361774)

  • 1. Hearing thresholds in CAPD patients.
    Morton LP; Reynolds L; Zent R; Rayner BL
    Adv Perit Dial; 1992; 8():150-2. PubMed ID: 1361774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD.
    Tokgoz B; Somdas MA; Ucar C; Kocyigit I; Unal A; Sipahioglu MH; Oymak O; Utas C
    Ren Fail; 2010 Jan; 32(2):179-84. PubMed ID: 20199179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.
    Tokgoz B; Ucar C; Kocyigit I; Somdas M; Unal A; Vural A; Sipahioglu M; Oymak O; Utas C
    Nephrol Dial Transplant; 2011 Dec; 26(12):4073-8. PubMed ID: 21551083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin.
    van der Hulst RJ; Boeschoten EW; Nielsen FW; Struijk DG; Dreschler WD; Tange RA
    ORL J Otorhinolaryngol Relat Spec; 1991; 53(1):19-22. PubMed ID: 2008289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment with continuous ambulatory peritoneal dialysis. One year observation].
    Stompór T; Sułowicz W; Bucki J
    Przegl Lek; 1997; 54(1):10-4. PubMed ID: 9190626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis (CRPD)--an initial Indian experience.
    Singh NP; Gupta S; Chandra J; Anuradha S; Kohli R; Rizvi SN
    J Indian Med Assoc; 2005 Jan; 103(1):22, 24, 26 passim. PubMed ID: 16008326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous ambulatory peritoneal dialysis: three years' experience.
    Ramos JM; Gokal R; Siamopolous K; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(206):165-86. PubMed ID: 6611839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
    Møller JK; Hagelskjaer LH
    Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel.
    Benjamin J; Ben-Ezer Gradus D; Mostoslavski M; Rapoport J; Chaimovitz C
    Isr J Med Sci; 1989 Dec; 25(12):699-702. PubMed ID: 2613500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system.
    Ghahramani N; Gorban-Brennan N; Kliger AS; Finkelstein FO
    Adv Perit Dial; 1995; 11():164-7. PubMed ID: 8534695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fungal peritonitis during continuous ambulatory peritoneal dialysis (CAPD)].
    García-Martos P; Díaz Portillo J; Pérez Ruilópez MA; Castaño López MA; Fernández Gutiérrez del Alamo C
    Enferm Infecc Microbiol Clin; 1991 Jan; 9(1):30-2. PubMed ID: 2029556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endstage renal failure due to polycystic kidney disease managed by continuous ambulatory peritoneal dialysis.
    Graham AN; Neale TJ; Hatfield PJ; Morrison RB; Meech PR; Jacobson A; Faircloth C
    N Z Med J; 1986 Jul; 99(805):491-3. PubMed ID: 3461382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida peritonitis in 2 patients on continuous ambulatory peritoneal dialysis (CAPD).
    Bozkurt F; Keller E; Schollmeyer P; Kappe R; Müller J
    Mycoses; 1988; Suppl 1():69-74. PubMed ID: 3252163
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea.
    Taegtmeyer M; Saxena R; Corkill JE; Anijeet H; Parry CM
    J Clin Microbiol; 2006 Aug; 44(8):3040-1. PubMed ID: 16891538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients.
    Were AJ; Marsden A; Tooth A; Ramsden R; Mistry CD; Gokal R
    Clin Nephrol; 1992 Apr; 37(4):209-13. PubMed ID: 1582059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
    Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
    Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-8 in chronic renal failure and dialysis patients.
    Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
    Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.